Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study

BACKGROUND: While recent years have seen a revolution in the treatment of metastatic cutaneous melanoma, no treatment has yet been able to demonstrate any prolonged survival in metastatic uveal melanoma. Thus, metastatic uveal melanoma remains a disease with an urgent unmet medical need. Reports of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jespersen, Henrik, Olofsson Bagge, Roger, Ullenhag, Gustav, Carneiro, Ana, Helgadottir, Hildur, Ljuslinder, Ingrid, Levin, Max, All-Eriksson, Charlotta, Andersson, Bengt, Stierner, Ulrika, Nilsson, Lisa M., Nilsson, Jonas A., Ny, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498539/
https://www.ncbi.nlm.nih.gov/pubmed/31046743
http://dx.doi.org/10.1186/s12885-019-5623-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498539/
https://www.ncbi.nlm.nih.gov/pubmed/31046743
http://dx.doi.org/10.1186/s12885-019-5623-3

Ejemplares similares